Couple screening to avoid thalassemia: Successful in Iran and instructive for us all

Journal of Medical Screening

Volumn 12, Issue 2, 2005, Pages 55-56

  Haddow, J E ^a  

^a WOMEN AND INFANTS HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EDITORIAL; FEMALE; FETUS; GENE MUTATION; GENETIC SCREENING; HEALTH CARE POLICY; HETEROZYGOTE; HUMAN; IRAN; MALE; PREGNANCY TERMINATION; PRENATAL DIAGNOSIS; RISK ASSESSMENT; SOCIAL ASPECT; SOUTHERN EUROPE; THALASSEMIA; UNITED STATES;

ABORTION, INDUCED; FAMILY HEALTH; FEMALE; GENETIC COUNSELING; GENETIC SCREENING; HUMANS; IRAN; MALE; MASS SCREENING; PREGNANCY; PRENATAL DIAGNOSIS; THALASSEMIA; UNITED STATES;

EID: 20644467771     PISSN: 09691413     EISSN: None     Source Type: Journal    
DOI: 10.1258/0969141053908375     Document Type: Editorial

References (8)

1. Samavat A, Modell B. Iranian national thalassemia screening programme. BMJ 2004;329:1134-7
2. Wald NJ. Couple screening for cystic fibrosis. Lancet 1991;338:1318-9
3. Wald N, Cuckle H. Reporting the assessment of screening and diagnostic tests. BJOG 1989;96:389-96
4. Angastiniotis M, Modell B, Englezos P, Boulyjenkov V. Prevention and control of haemoglobinopathies. Bull WHO 1995;73:375-86
5. Maggio A, Caronia F, Orlandi F. Prenatal diagnosis of haemoglobinopathies in Sicily. Lancet 1992;339:1361-2
6. Doherty RA, Palomaki GE, Kloza EM, et al. Couple-based prenatal cystic fibrosis screening in prenatal settings. Prenat Diag 1996;16:397-404
7. Bradley IA, Palomaki GE, Hyman D, Richards CS, Haddow JE. Prenatal cystic fibrosis (CF) screening: barriers to demonstrating clinical validity and utility in practice. ACMG Annual Clinical Genetics Meeting, March 2003, abstract 164:88
8. Grody WW, Cutting GR, Klinger KW, et al. Laboratory standards and guidelines for population-based cystic fibrosis carrier screening. Genet Med 2001;3:149-54